SanaHeal develops nature-inspired bioadhesive technology platforms designed to provide rapid, robust, and biocompatible tissue adhesion in challenging clinical environments, including wet or contaminated surgical settings.
SanaHeal, Inc. is a biotechnology company developing a nature-inspired bioadhesive platform designed for the repair and healing of injured biological tissues and organs. The technology utilizes synthetic and plant-derived biomaterials to overcome challenges such as moisture, blood, and surface contaminants. By mimicking mechanisms found in nature, such as the adhesion of barnacles and spider webs, the bioadhesives repel liquids and absorb moisture from biological surfaces to form immediate, robust, and air-tight or liquid-tight seals. The platform is engineered for versatility, allowing the material to be adapted into various form factors—including pastes and patches—and potentially incorporating additional functions like drug delivery or electrical conductivity.
This technology addresses critical needs in healthcare, specifically for managing hemorrhage and sealing injuries in difficult, wet, or contaminated clinical environments. By providing a rapid, coagulation-independent method for tissue adhesion, SanaHeal aims to improve surgical outcomes and wound care. The company, which is a spinout from MIT, has published pre-clinical studies in peer-reviewed journals such as Nature and Nature Biomedical Engineering, demonstrating its potential for applications like haemostatic sealing and diabetic wound healing. The company serves the medical and healthcare sectors, focusing on creating scalable solutions to improve the repair and recovery processes for patients.